Resolve Biosciences empowers scientists with Molecular Cartography™ to gain new insights into spatial biology and advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, infectious disease, and agriculture.
Resolve Biosciences Read More »
ImmunoScape is a pre-clinical biotechnology company developing next-generation TCR cell therapies for cancer.
RVAC Medicines is a mRNA biopharmaceutical company that develops innovative mRNA vaccines and therapeutics for unmet medical needs.
Aspen Neuroscience combines stem cell biology with the latest artificial intelligence and genomic approaches to investigate patient-specific, restorative treatments.
Aspen Neuroscience Read More »
A technology-driven company that empowers transformative cell and gene therapies through an integrated technologies model, combining R&D platforms and process development for discovery and development of advanced therapeutics.
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates to improve the quality of life and survival for people with cancer.
I-Mab is a full-stack biopharmaceutical company equipped to discover and develop best- and first-in-class biologics with global potential to treat cancer and auto-immune diseases.
I-MAB Biopharmaceutical Read More »
Deciphering complex biology with NetMAPPR platform, integrating data science, machine learning, high-throughput experiments, combinatorial genetics, and drug discovery, to yield promising drug targets for precision oncology therapeutics.
Engine Biosciences Read More »
US2.AI (formerly eko.ai) is automating the fight against heart disease, using AI software to simplify and democratize ultrasound of the heart, the most commonly used tool for the detection of cardiovascular risk.
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.
